Ingenious e-Brain Solutions

Turkey has been waiting for decades to adopt a unified law on the protection of Intellectual property (IP) rights. With the new IP Law no. 6769, in force as of January 10th, 2017, this reformed IP law is the first of its kind, regulating, patents, trademarks, designs, and geographical indications under one umbrella. In this amendment, the IP Law changed the name of the Turkish Patent Institute to the Turkish Patent and Trademark Office; simplifies the proceedings; and adopts a better system for protection and enforcement of industrial property rights by recognizing co-existence agreements and consent letters for trademarks. The IP Law amendment offers incentives for inventors as well by offering better support for R&D activities, introduction of post grant opposition, expansion of compulsory license criteria, getting rid of unexamined patents, acknowledging traditional product names together with geographical indications. In another significant move, the competent authority i...

Dr. D. C. Tayal, Ingenious e Brain Solutions, explores the implementation of US FDA’S new rule pertaining to laws that govern the submission and approval of AND A and 505b (2) applications, which maintains a balance between the generic drugs approval and acknowledging the innovation presented by brand name drugs. The US Food and Drug Administration (FDA) has introduced a significant change in the arena of pharmaceutical patents through its decision to revamp the rules pertaining to Medicare Prescription Drug, Improvement, and Modernization Act (MMA), 2003. The new regulations – referred to as final rule – were published in the federal register on October 6, 2016, under the title “Abbreviated New Drug Applications and 505(b)(2) Applications”. These revised rules have been effective from December 5, 2016. The final rule published by FDA is an implementation of the part of the rules it proposed in February 2015. Read More about this Click here  https://goo.gl/4WsReT

The Remark Can You Patent Your Invention is nowdays most askable question. The Idea is the First step towards the invention and undoubtedly, an inventor think about any invention only when they have any idea. The Journey between where you are now and where you want to be is same the journey between your idea and your Invention. The First step of this Journey is to understand what type of inventions and ideas are capable of patent. There are three types of Patent for which you can apply i.e. utility patents, design patents, or plant Patents. So, you need to understand your patent type for which you want to apply. After that, to determine if your idea can be patented, review the USPTO Office list of what can and cannot be patented which is also available online. Your Idea should be count as an invention if it is unique and not available in the USPTO List. There is a question which pops out in your mind that will it be useful or not?so, before going for patent ask yourse...

The  CRISPR /Cas systems (clustered, regularly interspaced, short palindromic repeats (CRISPR)–CRISPR-associated protein) represent a versatile tool for genome engineering, has been hailed as the “Breakthrough of the Year” for 2015, and rightfully so. The CRISPR/Cas originates from type II CRISPR/Cas systems, which provide bacteria and archaea with adaptive immunity for defense against viruses and plasmids by cleaving its nucleic acid. Functional CRISPR/Cas loci comprise a CRISPR array of identical repeats intercalated with invader DNA-targeting spacers that encode the crRNA components and an operon of cas genes encoding the Cas protein components. CRISPR mediated immunity mainly occurs in three stages i.e. (i) insertion of a short sequence of the invading DNA as a spacer sequence into the CRISPR array; (ii) transcription of precursor crRNA (pre-crRNA) that undergoes maturation to generate individual crRNAs, each composed of a repeat portion and an invader targeting spacer portio...

Nearly 44 million people have Alzheimer’s or a related dementia and every 66 seconds in the US develops Alzheimer’s disease. Alzheimer’s or dementia, a chronic impairment of brain functions marked mainly by memory problems and behavioral changes with a huge impact on patients and families. Many multinational pharmaceutical companies have their drug candidates in clinical trials raising hopes that an effective treatment could be finally within reach. However, several decades of research, and hundreds of failed Alzheimer’s disease trials, including recent failure of Eli Lilly’s solanezumab, we still know very little about this disease and it has no cure. Now, a team of researchers at Cambridge University could be one step closer to a cure for Alzheimer's after discovering how a key process that triggers the disease takes place. The signature hallmark of the disease - the most common form of dementia - is the build-up of protein plaques in the brain. Scientists believe t...

Patent Proofreading Proofreading is an important step for identifying errors that can lead to office actions or rejection of patent applications. Our team performs compromised patent proofreading by using a combination of electronic and manual proof reading processes. Our proofreaders deliver high quality results by following specific standardized  guidelines for checking grammar, spellings, formatting, antecedent basis, claim dependency, and claims/drawing consistency. Read more    https://goo.gl/xQrP8E